AI Verdict
RLAY has stronger fundamentals based on our AI analysis.
RLEA vs RLAY Fundamental Comparison
| Metric | RLEA | RLAY |
|---|---|---|
| Revenue | $4.9M | $15.4M |
| Net Income | $2.9M | $-276.5M |
| Net Margin | 58.5% | -1,800.6% |
| ROE | 998.3% | -48.8% |
| ROA | 47.1% | -44.5% |
| Current Ratio | 0.58x | 22.61x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.07 | $-1.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLEA vs RLAY: Frequently Asked Questions
Is RLEA or RLAY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RLAY has stronger fundamentals. RLEA is rated STRONG SELL (85% confidence) while RLAY is rated SELL (78% confidence). This is not investment advice.
How does RLEA compare to RLAY fundamentally?
Rubber Leaf Inc has ROE of 998.3% vs Relay Therapeutics, Inc.'s -48.8%. Net margins are 58.5% vs -1,800.6% respectively.
Which stock pays higher dividends, RLEA or RLAY?
RLEA has a dividend yield of N/A or no dividend while RLAY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLEA or RLAY for long term?
For long-term investing, consider that RLEA has STRONG SELL rating with 85% confidence, while RLAY has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLEA vs RLAY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLEA vs RLAY, the AI consensus favors RLAY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.